Growth Metrics

Inogen (INGN) Net Income Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 99.11%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4,440.69%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.10%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Inogen 165.85 Mn 71.44 Mn 37.86 Mn -34.82%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -34.82%
Dec 31, 2025 -137.77%
Sep 30, 2025 11.22%
Jun 30, 2025 25.72%
Mar 31, 2025 57.65%
Dec 31, 2024 87.19%
Sep 30, 2024 86.96%
Jun 30, 2024 43.11%
Mar 31, 2024 28.36%
Dec 31, 2023 -196.38%
Sep 30, 2023 -380.95%
Jun 30, 2023 -185.47%
Mar 31, 2023 -43.16%
Dec 31, 2022 273.36%
Sep 30, 2022 -178.08%
Jun 30, 2022 -167.46%
Mar 31, 2022 -1,841.80%
Dec 31, 2021 -213.28%
Sep 30, 2021 816.54%
Jun 30, 2021 97.75%
Mar 31, 2021 53.93%
Dec 31, 2020 -272.44%
Sep 30, 2020 -124.76%
Jun 30, 2020 -74.61%
Mar 31, 2020 -129.97%
Dec 31, 2019 -113.69%
Sep 30, 2019 -58.23%
Jun 30, 2019 -30.46%
Mar 31, 2019 -50.72%
Dec 31, 2018 1,757.59%
Sep 30, 2018 123.93%
Jun 30, 2018 75.22%
Mar 31, 2018 81.36%
Dec 31, 2017 -111.52%
Sep 30, 2017 39.88%
Jun 30, 2017 11.29%
Mar 31, 2017 135.30%
Dec 31, 2016 36.34%
Sep 30, 2016 94.58%
Jun 30, 2016 116.59%
Mar 31, 2016 60.37%
Dec 31, 2015 153.98%
Sep 30, 2015 26.39%
Jun 30, 2015 51.31%
Mar 31, 2015 77.03%
Dec 31, 2014 -93.09%
Sep 30, 2014 175.58%
Jun 30, 2014 16.63%
Mar 31, 2014 21.64%